PERGOVERIS Trademark

Trademark Overview

On Tuesday, October 5, 2021, a trademark application was filed for PERGOVERIS with the United States Patent and Trademark Office. The USPTO has given the PERGOVERIS trademark a serial number of 79324564. The federal status of this trademark filing is REGISTERED as of Tuesday, July 12, 2022. This trademark is owned by Merck KGaA. The PERGOVERIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of infertility and diseases and disorders relating to fertility
pergoveris

General Information

Serial Number79324564
Word MarkPERGOVERIS
Filing DateTuesday, October 5, 2021
Status700 - REGISTERED
Status DateTuesday, July 12, 2022
Registration Number6784258
Registration DateTuesday, July 12, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of infertility and diseases and disorders relating to fertility

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Monday, November 14, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 21, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 21, 2022FINAL DISPOSITION PROCESSED
Wednesday, October 12, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 12, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 12, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 3, 2022NOTIFICATION PROCESSED BY IB
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 13, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 13, 2022REFUSAL PROCESSED BY IB
Friday, January 21, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 20, 2022REFUSAL PROCESSED BY MPU
Wednesday, December 29, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 28, 2021NON-FINAL ACTION WRITTEN
Thursday, December 16, 2021ASSIGNED TO EXAMINER
Friday, November 5, 2021APPLICATION FILING RECEIPT MAILED
Monday, November 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 29, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

pergoveris disorders relating fertility diseases infertility preparations human treatment pharmaceutical